Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now indicates Revision: v3.3.2; the content shown (study details, criteria, and results) appears unchanged compared to the previous revision. No new content or functional changes are visible in the screenshot.
    Difference
    0.1%
    Check dated 2025-12-01T17:45:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.2.0 to v3.3.1, which does not alter any study data, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:35:51.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A funding-status notice was removed from the page. The study details and eligibility information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:50:38.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T01:17:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T09:56:34.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:10:01.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.